ACT vs CQ With Tafenoquine for P. Vivax Mono-infection

Clinical trial NCT05788094 · RECRUITING

Trial details

NCT number: NCT05788094
Sponsor: Shoklo Malaria Research Unit
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Malaria Malaria, Vivax Plasmodium Vivax Malaria

Start date: 2023-06-26
Primary completion: 2026-02-28
Enrollment: 606

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.